T. Rowe Price U.S. Equity Research ETF (TSPA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
T. Rowe Price U.S. Equity Research ETF (TSPA) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $2.20B, listed on AMEX, employing roughly 129 people, carrying a beta of 1.01 to the broader market. TSPA invests in US-listed companies in an attempt to provide exposure similar to its benchmark, the S&P 500 an index composed of the 500 largest publicly traded US firms. Led by Gavin MacBeath, public since 2021-06-14.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for TSPA as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.